In:
Blood, American Society of Hematology, Vol. 129, No. 24 ( 2017-06-15), p. 3227-3236
Kurzfassung:
Differential diagnosis of pre-PMF and overt PMF by 2016 WHO criteria underscores uniqueness in disease presentation and outcome. Patterns of driver and nondriver myeloid gene mutations contribute to prognosis in both pre-PMF and overt PMF.
Materialart:
Online-Ressource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2017-01-761999
Sprache:
Englisch
Verlag:
American Society of Hematology
Publikationsdatum:
2017
ZDB Id:
1468538-3
ZDB Id:
80069-7